BLIXFULI Trademark

Trademark Overview

On Monday, April 8, 2024, a trademark application was filed for BLIXFULI with the United States Patent and Trademark Office. The USPTO has given the BLIXFULI trademark a serial number of 98488461. The federal status of this trademark filing is WITHDRAWN BEFORE PUBLICATION as of Thursday, January 30, 2025. This trademark is owned by Gilead Sciences Ireland UC. The BLIXFULI trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
blixfuli

General Information

Serial Number98488461
Word MarkBLIXFULI
Filing DateMonday, April 8, 2024
Status692 - WITHDRAWN BEFORE PUBLICATION
Status DateThursday, January 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Monday, April 8, 2024NEW APPLICATION ENTERED
Sunday, September 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 21, 2024ASSIGNED TO EXAMINER
Friday, October 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 25, 2024NON-FINAL ACTION E-MAILED
Monday, January 27, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 27, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 25, 2024NON-FINAL ACTION WRITTEN
Monday, January 27, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 28, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 30, 2025ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Related Keywords

blixfuli preparations pharmaceutical treatment disorders diseases anti respiratory autoimmune pulmonary kidney